ORA, Inc.
68
1
4
55
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
10.3%
7 terminated/withdrawn out of 68 trials
88.7%
+2.2% vs industry average
34%
23 trials in Phase 3/4
53%
29 of 55 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (68)
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
Role: collaborator
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
Role: collaborator
AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
Role: collaborator
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
Role: lead
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Role: collaborator
Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)
Role: collaborator
Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.
Role: collaborator
A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test
Role: collaborator
Phase 3 Safety Study for the Treatment of Presbyopia Subjects
Role: collaborator
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Role: collaborator
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Role: collaborator
A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)
Role: collaborator
A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses
Role: lead
Visual Function Tests in Age-related Macular Degeneration
Role: lead
Efficacy Study of Ketorolac and HPMC to Treat Dry Eye
Role: lead
Study of ST-100 as Treatment for Dry Eye Disease
Role: collaborator
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
Role: lead
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
Role: collaborator
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
Role: lead
Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
Role: collaborator